Has Polyxene Kokinos, MD received payments from drug or device companies?

Yes. Drug and device makers reported $26,079 in general payments to Polyxene Kokinos, MD across 394 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Polyxene Kokinos, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Polyxene Kokinos, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Polyxene Kokinos, MD

Vascular Surgery · Campbell, CANPI 1679671259

Payments from drug & device makers

$26,079in general payments, 2019–2025

Across 394 payments — averaging $66.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$9K
Abbott$6K
Cardiovascular Systems Inc.$2K
Silk Road Medical, Inc.$2K
Terumo Medical Corporation$1K
Endologix LLC$1K
plus $6K from 34 others

What the payments were for

Travel & lodging$11,29043%
Food & beverage$14,65156%
Education$1381%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(3 entities)	120	$8,607
Abbott	67	$6,054
Cardiovascular Systems Inc.	19	$1,760
Silk Road Medical, Inc.	13	$1,637
Terumo Medical Corporation	17	$1,287
Endologix LLC	6	$1,138
Bard Peripheral Vascular, Inc.	24	$973
Johnson & Johnson(2 entities)	28	$849
Boston Scientific	17	$560
Shockwave Medical, Inc	6	$441
Biotissue Holdings Inc.	5	$281
Angiodynamics, Inc.	9	$278
Penumbra, Inc.	5	$268
Philips North America LLC	8	$253
BD	5	$218
Smith+Nephew	6	$202
Insightec,inc	1	$143
AbbVie	1	$125
W. L. Gore & Associates, Inc.	3	$119
Organogenesis Inc.	2	$85
Mozarc Medical US LLC	1	$82
Cordis US CORP.	3	$81
Koya Medical, Inc.	4	$73
Inari Medical, Inc.	3	$61
Urgo Medical North America, LLC	2	$49
Mimedx Group, Inc.	2	$48
Catheter Precision, Inc. FKA Ra Medical Systems, Inc.	2	$43
KCI USA, Inc.	1	$40
Asahi Intecc USA, Inc.	2	$36
Convatec Inc.	2	$33
Avita Medical Americas, LLC	1	$31
Siemens Medical Solutions USA, Inc.	1	$31
Surmodics, Inc.	1	$30
Baylis Medical Technologies Inc.	1	$29
Kiniksa Pharmaceuticals International, PLC	1	$25
Integra Lifesciences Corporation	1	$24
Stryker	1	$24
Biocompatibles, Inc.	1	$23
Baxter Healthcare	1	$17
Cardinal Health 200 LLC	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$26,079 in reported general payments places this provider in the 80th percentile of 519 vascular surgery providers in California.

See all vascular surgery providers in California →

Medicare billing

Part B allowed, 2024

$1,963,975

Medicare patients

1,027

Services billed

5,792

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
ClopidogrelClopidogrel Bisulfate	14	$303

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Campbell

Venita ChandraPalo Alto$947K
Leigh Ann ObanionFresno$932K
Sukgu HanLos Angeles$765K
Mahmoud Malasla Jolla$508K
Son DuongFountain Valley$503K
Leo FongClovis$496K
Jason LeePalo Alto$403K
Bernardo Curi MendesLos Angeles$376K
Trevor DerderianRancho Mirage$359K
Karthikeshwar KasirajanPalo Alto$349K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →